Zura Bio Limited - Class A Ordinary shares (ZURA)
Frequently Asked Questions About Zura Bio Limited - Class A Ordinary shares (ZURA)
How does Zura Bio Limited engage with investors?
Zura Bio Limited engages with investors through regular communications, including earnings calls, investor presentations, and participation in industry conferences. The company is committed to transparency and provides updates on its research progress, financial performance, and strategic initiatives to keep investors informed and engaged.
How does Zura Bio Limited ensure compliance with regulations?
Zura Bio Limited maintains a robust compliance framework that adheres to regulatory standards set forth by governing bodies such as the U.S. Food and Drug Administration (FDA). The company conducts its research and clinical trials in accordance with Good Clinical Practice (GCP) guidelines, ensuring that all data generated is reliable and meets safety requirements.
How is Zura Bio Limited funded?
Zura Bio Limited is funded through various sources, including public equity offerings, private investments, and research grants. The company strategically utilizes these funds to support its research and development activities, ensuring that it has the necessary resources to advance its clinical programs and bring therapies to market.
Is Zura Bio Limited publicly traded?
Yes, Zura Bio Limited is publicly traded on the Nasdaq stock exchange under the ticker symbol ZURA. The company went public as part of its strategy to raise capital for its ongoing research and development initiatives and to enhance its visibility within the biotechnology sector.
What are Class A Ordinary shares?
Class A Ordinary shares are a type of equity security that typically grants shareholders additional voting rights compared to other classes of shares. At Zura Bio Limited, Class A shares provide investors with the opportunity to participate in the company’s growth and strategic direction while also benefiting from any potential financial appreciation.
What are the clinical trial stages for Zura Bio Limited's products?
Zura Bio Limited's product candidates typically progress through various phases of clinical trials, starting from preclinical testing to Phase 1, Phase 2, and eventually Phase 3 trials. Each stage is designed to evaluate the safety, tolerability, and efficacy of the therapies in human subjects, with the ultimate goal of obtaining regulatory approval for commercialization.
What are the future growth prospects for Zura Bio Limited?
Zura Bio Limited's future growth prospects are viewed positively, driven by its innovative pipeline of therapeutic candidates and the increasing demand for effective treatments for autoimmune and inflammatory diseases. With a strong focus on research and strategic partnerships, the company aims to expand its market presence and achieve regulatory approvals for its products.
What are Zura Bio Limited's lead products?
Zura Bio Limited is currently developing several lead product candidates, which are in various stages of clinical trials. These candidates target specific pathways involved in autoimmune responses, aiming to reduce disease symptoms and improve health outcomes for patients suffering from conditions like rheumatoid arthritis and lupus.
What are Zura Bio Limited's long-term goals?
Zura Bio Limited's long-term goals include advancing its clinical pipeline to obtain regulatory approvals for its therapeutic candidates, expanding its market presence, and ultimately improving patient outcomes in autoimmune conditions. The company aims to establish itself as a leader in the biotechnology industry through scientific innovation and commitment to patient care.
What challenges does Zura Bio Limited face?
Like many biotechnology companies, Zura Bio Limited faces challenges such as regulatory hurdles, the complexity of clinical trials, and the need for substantial funding to support its research initiatives. Additionally, market competition and the risk of potential clinical failures pose ongoing challenges that the company must navigate to achieve its goals.
What does Zura Bio Limited do?
Zura Bio Limited is a biotechnology company focused on developing innovative therapies to treat autoimmune and inflammatory diseases. The company is dedicated to addressing unmet medical needs through its scientific expertise and commitment to research and development. By leveraging advanced technologies, Zura Bio aims to discover and commercialize novel therapeutics that improve patient outcomes.
What is the competitive landscape for Zura Bio Limited?
The competitive landscape for Zura Bio Limited includes various biotechnology firms and pharmaceutical companies focused on similar therapeutic areas. To differentiate itself, Zura Bio aims to leverage its unique scientific approach, innovative drug candidates, and commitment to patient-centric solutions, positioning itself favorably within the industry.
What is the research focus of Zura Bio Limited?
The research focus of Zura Bio Limited centers around autoimmune and inflammatory diseases, where the company seeks to identify novel therapeutic targets and develop cutting-edge treatment options. By employing rigorous scientific research and clinical validation, Zura Bio aims to bring groundbreaking therapies to patients who currently lack effective treatment alternatives.
What is the significance of Zura Bio Limited's pipeline?
The significance of Zura Bio Limited's pipeline lies in its potential to deliver novel therapies that address significant unmet medical needs in autoimmune and inflammatory diseases. A robust pipeline can enhance the company's competitive positioning and provide opportunities for future revenue generation, serving as a key driver of business growth.
What is Zura Bio Limited’s mission?
Zura Bio Limited's mission is to transform the treatment landscape for autoimmune and inflammatory diseases by discovering and developing safe and effective therapies. The company is committed to scientific excellence and strives to improve patients' quality of life through innovative biopharmaceutical solutions.
What partnerships does Zura Bio Limited have?
Zura Bio Limited actively seeks partnerships with academic institutions, research organizations, and pharmaceutical companies to enhance its research capabilities and accelerate its drug development programs. Collaborations may include joint research initiatives, co-development agreements, or licensing arrangements aimed at leveraging shared expertise and resources.
When was Zura Bio Limited founded?
Zura Bio Limited was founded in 2020, with the vision of advancing biopharmaceutical solutions for patients suffering from chronic inflammatory conditions. Since its inception, the company has made significant strides in its research endeavors and has positioned itself as a promising player in the biotechnology space.
Where is Zura Bio Limited located?
Zura Bio Limited is headquartered in the United States, where it operates its main research and development facilities. The strategic location allows the company to closely collaborate with key research institutions, healthcare professionals, and regulatory bodies, facilitating its mission to bring new therapies to market efficiently.
Who are the key executives at Zura Bio Limited?
Zura Bio Limited has a team of experienced executives and scientists leading its operations, including a Chief Executive Officer with a strong background in biopharmaceutical development and a Chief Financial Officer skilled in capital markets. These leaders are dedicated to guiding the company's strategic vision and ensuring the successful advancement of its therapeutic candidates.
What is the current price of Zura Bio Limited - Class A Ordinary shares?
The current price of Zura Bio Limited - Class A Ordinary shares is 2.990
When was Zura Bio Limited - Class A Ordinary shares last traded?
The last trade of Zura Bio Limited - Class A Ordinary shares was at 4:00 pm EDT on September 29th, 2025
What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?
The market capitalization of Zura Bio Limited - Class A Ordinary shares is 185.57M
How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?
Zura Bio Limited - Class A Ordinary shares has 62.06M shares outstanding.